Trial Profile
A Phase IV, Open-label, Multi-center, Community-based Trial in Asia Studying the Safety and Efficacy of Keppra™ as Adjunctive Therapy in Adult Subjects With Uncontrolled Partial Epilepsy.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 21 Aug 2020
Price :
$35
*
At a glance
- Drugs Levetiracetam (Primary)
- Indications Partial epilepsies
- Focus Adverse reactions
- Sponsors UCB Pharma Inc
- 16 Jul 2007 Status change from in progress to completed.
- 30 Sep 2006 New trial record.